Basal ganglia choline levels in depression and response to fluoxetine treatment: An in vivo proton magnetic resonance spectroscopy study
- 15 April 1997
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 41 (8) , 837-843
- https://doi.org/10.1016/s0006-3223(96)00256-9
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Analysis of magnetic resonance spectra by mole percent: Comparison to absolute unitsNeurobiology of Aging, 1994
- Proton‐decoupled 31P chemical shift imaging of the human brain in normal volunteersNMR in Biomedicine, 1993
- Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brainNeurochemistry International, 1993
- Choline metabolism as a basis for the selective vulnerability of cholinergic neuronsTrends in Neurosciences, 1992
- Comparison of single‐shot localization methods (steam and press) for In vivo proton NMR spectroscopyNMR in Biomedicine, 1989
- Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolitesMagnetic Resonance in Medicine, 1989
- Broadband proton decoupling in human 31p NMR spectroscopyNMR in Biomedicine, 1989
- A CHOLINERGIC-ADRENERGIC HYPOTHESIS OF MANIA AND DEPRESSIONThe Lancet, 1972
- Large sample standard errors of kappa and weighted kappa.Psychological Bulletin, 1969
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960